Natriuretic peptide testing for predicting adverse events following heart failure hospitalization - Wikidata - awgldk - TriplyDB

Natriuretic peptide testing for predicting adverse events following heart failure hospitalization

Natriuretic peptide testing for predicting adverse events following heart failure hospitalization

http://www.wikidata.org/entity/Q27008553

about

B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis Prognostic significance of a multimarker strategy of biomarkers in acute heart failure.The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.Database queries for hospitalizations for acute congestive heart failure: flexible methods and validation based on set theory.Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study.Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure.

P2860

Q26861828-47DF304A-FD04-405D-AE6E-24D06FBD8016 Q34479808-FB4D46D3-C663-451D-A2EF-C2DD8A0D1844 Q37506768-A4F15974-8D19-4989-97D0-F91AF5F6AE68 Q38151468-A12463A7-6A70-427A-8B6C-BFD74CE694DB Q38642916-09CC0279-D0DD-4821-9538-A70365CD2DA6 Q39127729-F6F50EBD-4D85-421B-8064-42788194B17D Q39496715-102ABE69-53F2-4B86-8ED9-B2D83D166D21 Q40487887-1BD972E8-055D-4211-B127-1C4F11CDC791

P2860

Natriuretic peptide testing for predicting adverse events following heart failure hospitalization

http://www.wikidata.org/entity/Q27008553

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Natriuretic peptide testing fo ...... heart failure hospitalization

@ast

Natriuretic peptide testing fo ...... heart failure hospitalization

@en

Natriuretic peptide testing fo ...... heart failure hospitalization

@nl

type

label

Natriuretic peptide testing fo ...... heart failure hospitalization

@ast

Natriuretic peptide testing fo ...... heart failure hospitalization

@en

Natriuretic peptide testing fo ...... heart failure hospitalization

@nl

prefLabel

Natriuretic peptide testing fo ...... heart failure hospitalization

@ast

Natriuretic peptide testing fo ...... heart failure hospitalization

@en

Natriuretic peptide testing fo ...... heart failure hospitalization

@nl

P1433

Q27008553-9D00FEC8-F5B5-4EC8-B0A1-A740B78021E4

P1476

Q27008553-21D9B9D0-B36C-43DC-977D-AA721D66CBA5

P2093

Q27008553-93323A2E-203C-4D8A-A167-12497615260E

Q27008553-C9C332FF-AA40-4BAA-B94C-42514809D790

Q27008553-D107E058-B3DA-4C5E-8111-D2E0AF007CF9

Q27008553-D3A562B2-4E17-4060-B058-993A842FD3A6

P2860

Q27008553-0DC285F3-8E2B-4E0B-A96C-D547C9F00A71

Q27008553-0E8369D1-0F52-4C6F-AF73-FED42CFC83B9

Q27008553-130B28B5-B5DB-4671-8CC7-742D14612CD0

Q27008553-2AD98300-75D6-4C95-AC3C-ECDD8C6C8DCB

Q27008553-38772E5A-CB62-4757-9C34-643582329528

Q27008553-3C10FA45-DDD7-4561-BA38-FB7D26DA53A3

Q27008553-3DD4C7C5-5C96-49F0-95BB-F753D33F48DD

Q27008553-413093EB-601F-4B76-9747-87C20DB0A764

Q27008553-4185FE6E-A1E7-4E10-8D97-E2F6865CE322

Q27008553-432FD52C-8870-4D47-B153-005F2FD64397

P304

Q27008553-666DFDC7-16AD-4CF3-9184-1DB983588C96

P31

Q27008553-8B15FD51-603B-48A0-A550-3D1728D886A2

P356

Q27008553-D3FE47D3-84ED-4F2D-93ED-F50082766ACD

P407

Q27008553-B0F82882-58C0-4FCF-851D-D58150EBA3F7

P478

Q27008553-9634900E-6C09-4B68-84DE-770FA74D57FB

P50

Q27008553-C9B6ED70-73D8-46F2-BE29-4820DFA71B65

P577

Q27008553-F85246E1-FD72-4522-B085-9DE27DBF44BA

P5875

Q27008553-B7CE28D1-5A9C-46FC-A11D-3C9A201BAE58

P698

Q27008553-74574B93-F421-4623-AE8C-3900B8A55300

P921

Q27008553-EDB5D194-5FDF-4EB6-8F9A-D257AEF9EE02

Q27008553-EDCFD250-7418-4747-B76B-26EA55BD4F71

P356

J.1751-7133.2012.00306.X

P1433

Congestive Heart Failure

P1476

Natriuretic peptide testing fo ...... heart failure hospitalization

@en

P2093

Alan S. Maisel

http://www.w3.org/2001/XMLSchema#string

Christopher DeFilippi

http://www.w3.org/2001/XMLSchema#string

Marc Silver

http://www.w3.org/2001/XMLSchema#string

Yang Xue

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.

Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results.

Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure.

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.

P304

S9-S13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1751-7133.2012.00306.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

18 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

James L Januzzi

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230746271

http://www.w3.org/2001/XMLSchema#string

P698

22891803

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization